KM
Keith S Manchester

Keith S Manchester insider trades: Roivant Sciences (ROIV) stock sales

Roivant Sciences Last trade Jun 30, 2026 25 Form 4 filings
$154.5M
Sold, last 12 months
5 sales
$0
Bought, last 12 months
0 buys
15
Open-market trades
since 2022
2
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Keith reports to the SEC

Open-market buys and sales

15 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jun 30, 2026ROIV↓ Sell$49.4M
Jun 30, 2026ROIV↓ Sell$7.1M
Feb 13, 2026ROIV↓ Sell$32.7M
Dec 17, 2025ROIV↓ Sell$39.1M
Nov 19, 2025ROIV↓ Sell$26.3M
Sep 25, 2024ROIV↓ Sell$5.9M
Aug 14, 2024ABUS↓ Sell$33K
Sep 28, 2023ROIV↓ Sell$35.3M
Sep 28, 2023ROIV↓ Sell$26.4M
Sep 28, 2023ROIV↓ Sell$12.8M
Sep 28, 2023ROIV↓ Sell$5.2M
Nov 10, 2022ROIV↓ Sell$11.0M
Nov 10, 2022ROIV↓ Sell$5.2M
Nov 10, 2022ROIV↓ Sell$1.8M
Nov 10, 2022ROIV↓ Sell$694K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other ROIV insiders

Open-market trades in the last 12 months

About Keith S Manchester's insider trades

Keith S Manchester is an insider at Roivant Sciences (ROIV). Since Nov 10, 2022, Keith has reported no open-market purchases and 15 sales worth $258.7M on SEC Form 4. In the last 12 months: 5 sales ($154.5M).

Their filings also include grants and awards (15 filings), other transactions (3 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ROIV insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.